|
Supported Event
November 6 - 7
Long Beach Convention Center
|
|
Thanks to the following for their continued support of
SoCalBio
|
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech, medtech and digital health industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth. SoCalBio has nearly 400 corporate members and sponsors.
|
|
Thanks to SoCalBio Media Partners
|
|
|
Prostate Cancer |
Seal Beach-Based Dendreon Completes Patient Enrollment in a Trial to Test the Effectiveness of Provenge in Treating Early-Stage Prostate Cancer
More than 450 subjects were randomized in the large-scale, third-phase clinical trial, which is evaluating the effectiveness of sipuleucel-T (PROVENGE®) in reducing disease progression in men with early-stage prostate cancer on active surveillance.
|
| Biosimilars |
Thousand Oaks-Based Amgen Reports Higher Biosimilars Sales, But Ends Neuroscience Program
According to Reuters, Amgen reported a drop in sales of its older drugs which sent third-quarter revenue down 3%, but biosimilar sales were strong.
Amgen, which last year launched migraine drug Aimovig, also said it would end programs to develop other neuroscience drugs.
|
| Animal Health |
Los Angeles-Based Gallant Launches Stem Cell Banking for Dogs Nationwide
According the company's press release, "Gallant obtains a dog's stem cells from tissues collected during a routine spay or neuter procedure. The young stem cells, which would otherwise be thrown away, are then cryopreserved to create life-changing treatments for future ailments. It is the first and only non-invasive animal stem cell collection method available today."
|
| Digital Health Conference |
Presentation, Sponsorship and Exhibiting Opportunities Available.
|
| Radiation Countermeasures |
Lancaster-Based Simulations Plus to Support the Development of Radiation Countermeasures
In partnership with
DILIsym Services Inc.
(DSS), Simulation Plus will spearhead the development of a new platform to allow for predicting the effects of radiation on mice, non-human primates, and humans, as well as the impact of interventions on radiation syndrome.
|
Digital Health
|
NantHealth's Eviti Connect platform seeks to align cancer treatment with evidence-based medicine. This digital health platform will be utilized by Wexford Health, a correctional health care company, to ensure inmates receive appropriate care for their oncologic conditions.
|
| SoCalBio Member Benefit |
Save up to 75% on Procurement of
Lab Supplies from
SoCalBio member companies enjoy s
ubstantial savings and benefits including, but not limited to:
- Savings of up to 75% from list on a hotlist of more than 2,700 items
- No shipping charges for products shipped from any of VWR's distribution center
- No fuel surcharge
- No hazardous material handling fees
- Generous rebates sent directly back to you on annual contract spend growth
To enroll, contact
SoCalBio
, at 800-418-7079 ext 3 or send email to
|
| Moving In |
Irvine-Based Modulim
Announces New CEO Richard Oberreiter
Modulim , a company developing optical imaging solutions for noninvasive tissue assessment, announced the appointment of Richard Oberreiter as its new Chief Executive Officer. Oberreiter succeeds Modulim's founder, CEO and Chief Technical Officer, David Cuccia, Ph.D., who will focus on exploring new applications of the company's platform technology, known as spatial frequency domain imaging.
|
| Moving Out |
Two Top Executives Leave Westlake Village-Based Atara Biotherapeutics
Atara Biotherapeutics Inc. late Friday announced the departures of Dr. Christopher Haqq, chief scientific officer, and Mina Kim, general counsel and head of corporate strategy. Atara, which has its major T-cell manufacturing operations in Westlake Village and Thousand Oaks for cancer therapy, has not announced new appointees for these roles.
|
|
|
About SoCalBio
|
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program
group purchasing program and other benefits you simply can't find elsewhere ...
Join SoCalBio
|
|
|
